These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39376163)

  • 1. Out of focus but still relevant? Influenza-related resource utilization and vaccination coverage gaps in adults below 60 years of age with underlying conditions: an analysis of 2016-2024 real-world data in Germany.
    Colombo L; Witte J; Gensorowsky D; Batram M; Hadigal S
    J Med Econ; 2024; 27(1):1337-1346. PubMed ID: 39376163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
    de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
    BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
    Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.
    Hu T; Miles AC; Pond T; Boikos C; Maleki F; Alfred T; Lopez SMC; McGrath L
    J Med Econ; 2024; 27(1):324-336. PubMed ID: 38343288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.
    Bödeker B; Remschmidt C; Schmich P; Wichmann O
    BMC Public Health; 2015 Jul; 15():618. PubMed ID: 26148480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of healthcare resource use and cost between influenza and COVID-19 vaccine coadministration and influenza vaccination only.
    Mehta D; Sun T; Wang J; Situ A; Park Y
    J Med Econ; 2024; 27(1):1190-1196. PubMed ID: 39231068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis.
    Damm O; Krefft A; Ahlers J; Kramer R; Witte J; Batram M; Schelling J; Greiner W
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13054. PubMed ID: 36181357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.
    Böhmer MM; Walter D; Falkenhorst G; Müters S; Krause G; Wichmann O
    BMC Public Health; 2012 Oct; 12():938. PubMed ID: 23113995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel.
    Kassianos G; Cohen JM; Civljak R; Davidovitch N; Pecurariu OF; Froes F; Galev A; Ivaskeviciene I; Kõivumägi K; Kristufkova Z; Kuchar E; Kyncl J; Maltezou HC; Marković M; Nitsch-Osuch A; Ortiz de Lejarazu R; Rossi A; Schelling J; van Essen GA; Zavadska D
    Expert Rev Respir Med; 2024; 18(3-4):69-84. PubMed ID: 38652642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L; Roiz J; Faivre P; Reygrobellet C
    Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the Effect of a National Pharmacy-Led Influenza Vaccination Voucher Program on Morbidity, Mortality, and Costs.
    Singh T; Taitel M; Loy D; Smith-Ray R
    J Manag Care Spec Pharm; 2020 Jan; 26(1):42-47. PubMed ID: 31880234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hospital Burden of Flu in Italy: a retrospective study on administrative data from season 2014-2015 to 2018-2019.
    Cipelli R; Falato S; Lusito E; Maifredi G; Montedoro M; Valpondi P; Zucchi A; Azzi MV; Zanetta L; Gualano MR; Xoxi E; Marchisio PG; Castaldi S
    BMC Infect Dis; 2024 Jun; 24(1):572. PubMed ID: 38851739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Jorgensen P; Mereckiene J; Cotter S; Johansen K; Tsolova S; Brown C
    Vaccine; 2018 Jan; 36(4):442-452. PubMed ID: 29287683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social determinants of health and adult influenza vaccination: a nationwide claims analysis.
    Gatwood J; Ramachandran S; Shuvo SA; Behal M; Hagemann T; Hohmeier KC; Chiu CY
    J Manag Care Spec Pharm; 2022 Feb; 28(2):196-205. PubMed ID: 35098752
    [No Abstract]   [Full Text] [Related]  

  • 18. Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013.
    Haas J; Braun S; Wutzler P
    Eur J Health Econ; 2016 Jul; 17(6):669-79. PubMed ID: 26143025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.
    Tuppin P; Samson S; Weill A; Ricordeau P; Allemand H
    Vaccine; 2011 Jun; 29(28):4632-7. PubMed ID: 21550376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.